Infokiri

Ad hoc workshop to exchange informa�on on increase of STIs in EU/EEA, in par�cular among young heterosexuals

Par�cipants: STI Network

ECDC

WHO EURO

Objec�ve:

The objective of the mee�ng is to facilitate a discussion to review what has been done or is being planned, in three main areas:

1. Understanding the underlying drivers behind this increase (e.g. behavioural data, data from WGS, network analyses)

2. Understanding the potential impact (projects designed to capture outcomes/impact – e.g. PID through hospital data, modelling studies)

3. Response (e.g. messaging, information campaigns, channels used)

Agenda:

Time Agenda item Presenter 14.00-14.05 Welcome and objec�ves of the mee�ng Lina Nerlander, ECDC 14.05-14.15 Overview of data and ongoing work O�lia Mardh, ECDC

Lina Nerlander, ECDC SESSION 1: Drivers and burden 14.15-14.25 Country presenta�on 1 TBD 14.25-14.35 Country presenta�on 2 TBD 14.35-14.45 Country presenta�on 3 TBD 14.45-15.15 Discussion

- Feedback on presentations - Shorter oral updates from other MS - General discussion

15.15-15.25 BREAK SESSION 2: Response 15.25-15.35 Country presenta�on 1 TBD 15.35-15.45 Country presenta�on 2 TBD 15.45-15.55 Country presenta�on 3 TBD 15.55-16.20 Discussion

- Feedback on presentations - Shorter oral updates from other MS - General discussion

16.20-16.30 Summary, ac�on points and next steps Lina Nerlander, ECDC

Saatja: SBT Meetings <[email protected]>

Saadetud: 24.04.2024 11:09

Adressaat: El-Khatib Ziad <[email protected]>; irene.kaszoni-

rueckerl <[email protected]>;

dominique.vanbeckhoven <[email protected]>;

jessika.deblonde <[email protected]>; mtyufekchieva

<[email protected]>; nvladimirova <[email protected]>;

tatjana.nemeth-blazic <[email protected]>; Mirjana Lana

Kosanović Ličina <[email protected]>; drelenax

<[email protected]>; georgiossiakallis <[email protected]>;

Fani Theophanous <[email protected]>; Christiana Stavraki

<[email protected]>; hana.zakoucka <[email protected]>; Anders

Koch <[email protected]>; Maria Wessman <[email protected]>; Hanna Maria Aavik

<[email protected]>; kristi.ruutel <[email protected]>;

Henrikki Brummer-Korvenkontio <[email protected]>; Kirsi Liitsola

<[email protected]>; KUNKEL Amber

<[email protected]>; Florence LOT

<[email protected]>; bremerv <[email protected]>; Georgia

Nikolopoulou <[email protected]>; Ioanna Magaziotou

<[email protected]>; kozma.emese <[email protected]>;

molnar.zsuzsanna <[email protected]>; Guðrún Aspelund - Landl

<[email protected]>; Anna Margrét Guðmundsdóttir - Landl

<[email protected]>; Erna Milunka Kojic

<[email protected]>; Niamh.Murphy <[email protected]>; Kate

ODonnell <[email protected]>; <[email protected]>; derval.igoe

<[email protected]>; Suligoi Barbara <[email protected]>;

mariaelena.tosti <[email protected]>; Walser-Domjan Esther

<[email protected]>; vilnele.lipnickiene

<[email protected]>; giedre.aleksiene

<[email protected]>; Jurgita Pakalniškienė

<[email protected]>; Patrick HOFFMANN

<[email protected]>; Joël Mossong <[email protected]>;

Jean-Claude Schmit <[email protected]>; Melillo Jackie M at

Health Regulation <[email protected]>; Melillo Tanya at Health

Regulation <[email protected]>; Birgit van Benthem

<[email protected]>; Eline Op de Coul

<[email protected]>; hilde.klovstad <[email protected]>;

kathrine.stene-johansen <[email protected]>; Niedźwiedzka-

Stadnik Marta <[email protected]>; Rui Tato Marinho

<[email protected]>; Vitor Verissimo

<[email protected]>; <[email protected]>; Mariana

Mardarescu <[email protected]>; Bražinová Alexandra

<[email protected]>; eva.chmelanova

<[email protected]>; Danica Staneková <[email protected]>;

tanja.kustec <[email protected]>; Irena Klavs <[email protected]>;

jamo <[email protected]>; Asunción Díaz Franco <[email protected]>;

maria.axelsson <[email protected]>; lena.dillner

<[email protected]>; anneli.carlander

<[email protected]>; Dam, Alje van

<[email protected]>; Amaryl.Lecompte <[email protected]>;

akouzmanov <[email protected]>; angeline.mcintyre

<[email protected]>; <[email protected]>; Antra Bormane

<[email protected]>; aurelija.petrutiene

<[email protected]>; bmlynarczyk <[email protected]>;

nadzonova <[email protected]>; <[email protected]>;

blazenka.hunjak <[email protected]>; BCrowley

<[email protected]>; boconnell <[email protected]>;

<[email protected]>; cecile.bebear <[email protected]>;

<[email protected]>; christopher.barbara

<[email protected]>; daan.notermans <[email protected]>;

<[email protected]>; denisa.janta <[email protected]>; dpieridou

<[email protected]>; d.paraskeva <[email protected]>;

Caugant, Dominique Andree Yvette <[email protected]>;

Dorien Van den Bossche <[email protected]>; utbrudd <[email protected]>;

papavr <[email protected]>; emilie.chazelle

<[email protected]>; emmi.sarvikivi

<[email protected]>; fogarassy.erika <[email protected]>;

balla.eszter <[email protected]>; fleur.van.aar

<[email protected]>; <[email protected]>; Gabriela Hartwig

<[email protected]>; gatis.pakarna <[email protected]>;

Gilles Delmas <[email protected]>; hagedorn

<[email protected]>; helena.zemlickova <[email protected]>;

ingibjh <[email protected]>; Irith De Baetselier

<[email protected]>; ivva.philipova <[email protected]>; Žofka

Jan Mgr. Ing. <[email protected]>; Jari Jalava <[email protected]>;

Gómez Castellá. Javier <[email protected]>; Jelena Razmuk

<[email protected]>; Jorge Machado <[email protected]

saude.pt>; Haider Julie at Health-MDH <[email protected]>; Princesa

Vazquez Abad <[email protected]>; Kairi Tõnsau

<[email protected]>; Zakrzewska Karolina

<[email protected]>; Kęstutis Rudaitis <[email protected]>;

jansenk <[email protected]>; <[email protected]>;

<[email protected]>; Lena Rós Ásmundsdóttir <[email protected]>;

Maartje Visser <[email protected]>; wenerologia <[email protected]>;

margaridatavares <[email protected]>; mariahadjivassiliou

<[email protected]>; Maria José Borrego

<[email protected]>; Maríanna Þórðardóttir - Landl

<[email protected]>; Mark Campbell

<[email protected]>; Marlen Timm <[email protected]>;

martha.neary <[email protected]>; <[email protected]>;

mirja.puolakkainen <[email protected]>; monica.aanei

<[email protected]>; Monique.perrin <[email protected]>;

nicolas.dupin <[email protected]>; olivia.peuchant

<[email protected]>; Panayiota Hadjikyprianou

<[email protected]>; pmaikanti <[email protected]>;

Stefanelli Paola <[email protected]>; slezak.pavel

<[email protected]>; Pedro Licinio Pinto Leite <[email protected]

saude.pt>; peter.kohl <[email protected]>; philippe.grange

<[email protected]>; polona.maver <[email protected]>;

Regina Russanova <[email protected]>; Cassar Robert at

Health-MDH <[email protected]>; romana.rebreanu

<[email protected]>; sanita.kuzmane

<[email protected]>; <[email protected]>;

solvita.selderina <[email protected]>; Sonja Pleininger

<[email protected]>; Steen Hoffmann <[email protected]>;

<[email protected]>; Susan Cowan <[email protected]>; Tuula Hannila-

Handelberg <[email protected]>; miriagou

<[email protected]>; vladislav.jakubu <[email protected]>;

vratislav.nemecek <[email protected]>; yankayankova

<[email protected]>

Koopia: NC_CCB_Austria <[email protected]>; sigrid.kiermayr

<[email protected]>; koen.blot

<[email protected]>; <[email protected]>; Zhivka Getsova

<[email protected]>; Iva Christova <[email protected]>; kcapak

<[email protected]>; bernard.kaic <[email protected]>; Elisavet

Constantinou <[email protected]>; <[email protected]>; Hana

Orlíková <[email protected]>; Kamilla Grønborg Laut <[email protected]>;

Stine Ulendorf Jacobsen <[email protected]>; TA Info <[email protected]>;

Natalia Kerbo <[email protected]>; Otto Helve

<[email protected]>; Savolainen-Kopra Carita <carita.savolainen-

[email protected]>; Paula Garcia-Lobato <Paula.garcia-

[email protected]>; Anne-Catherine VISO <anne-

[email protected]>; <[email protected]>; Rexroth, Ute

<[email protected]>; AnderHeidenMa <[email protected]>; Theodora

Kalomama <[email protected]>; Dimitrios Paraskevis

<[email protected]>; Christakis Chatzichristodoulou

<[email protected]>; <[email protected]>;

phc.office <[email protected]>; Rezsőfi Judit

<[email protected]>; Greg Martin <[email protected]>; Kate

Loughnane <[email protected]>; patricia.garvey

<[email protected]>; Louise Cullen <[email protected]>;

Lisa.Domegan <[email protected]>; Aine Grace <[email protected]>;

Francesco Maraglino <[email protected]>; Dehler Silvia, Dr. med.

<[email protected]>; greta.gargasiene <[email protected]>;

Gauci Charmaine at Health Regulation <[email protected]>;

Hester.de.Melker <[email protected]>; Susan van den Hof

<[email protected]>; Macdonald, Emily Ann

<[email protected]>; Heidi Lange <[email protected]>; Zacharczuk

Katarzyna <[email protected]>; Poznański Dariusz

<[email protected]>; Mariana Ferreira <[email protected]

saude.pt>; <[email protected]>; André Peralta Santos

<[email protected]>; Adriana Pistol <[email protected]>;

ecdc <[email protected]>; jan.mikas <[email protected]>; <[email protected]>;

Marta.vitek <[email protected]>; Fernando Simón Soria

<[email protected]>; <[email protected]>;

<[email protected]>; Agneta Falk Filipsson

<[email protected]>; Sara Bengtsson

<[email protected]>; birgitta.lesko

<[email protected]>; anette.richardson

<[email protected]>; Country Cooperation

<[email protected]>; Lina Nerlander

<[email protected]>; Otilia Mardh

<[email protected]>; Anastasia Pharris

<[email protected]>; inga.velicko

<[email protected]>; Padovese Valeska at Health-MDH

<[email protected]>; Paulke-Korinek, Maria <Maria.Paulke-

[email protected]>; Dr. Balla Eszter

<[email protected]>; adriana.mecochova

<[email protected]>; Charlotte Deogan

<[email protected]>; Janelle Sandberg

<[email protected]>; Galea Norman at MHA - Health

Regulation <[email protected]>; Thomas Lamot

<[email protected]>; Mária Avdičová <[email protected]>; Eva

Marie Blichfeldt-Moltke <[email protected]>; Steffen, Gyde <[email protected]>;

Birgir Jóhannsson <[email protected]>; Dr. Olga Apostolou (NGH)

<[email protected]>; Katerina Crawford

<[email protected]>; algirdas.griskevicius

<[email protected]>; romsocderm <[email protected]>;

GRANKOV, Viatcheslav <[email protected]>; Ivana Bozicevic

<[email protected]>; Jelena Barbaric

<[email protected]>; OTANI, Machiko <[email protected]>; Dhaeze

Wouter <[email protected]>; Kenneth Beatty

<[email protected]>; Caroline Hurley1 <[email protected]>;

Power, Antoinette (Microbiology) <[email protected]>; Muireann Kirby

<[email protected]>; Unemo Magnus, Labmed USÖ

<[email protected]>; Esther Kukielka Zunzunegui

<[email protected]>; Moa.Rehn

<[email protected]>; anna.ohlson

<[email protected]>; Derek Freedman <[email protected]>;

Manasvini Moni <[email protected]>; Disa Hansson

<[email protected]>; Piotr Kramarz

<[email protected]>

Teema: Ad hoc workshop to exchange information on increase of STIs in

EU/EEA, in particular among young heterosexuals

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu

saatja korral palume linke ja faile mitte avada.

To: STI Network (Operational contact points for epidemiology /

microbiology, National Focal points)

Cc: National Coordinators

Dear colleagues,

You are invited to attend a 2.5-hour meeting on Monday 29/4 at 14.00-

16.30 CET with ECDC and other Member States to discuss the recent

increases in STIs among young heterosexuals.

The aim of the meeting is to facilitate a discussion to review what has

been done or is being planned, in three main areas:

1. Understanding the underlying drivers behind this increase (e.g.

behavioural data, data from WGS, network analyses)

2. Understanding the potential impact (projects designed to capture

outcomes/impact e.g. PID through hospital data, modelling studies)

3. Response (e.g. messaging, information campaigns, channels used)

In addition to reviewing any results available, this also provides an

opportunity for countries to share protocols and plans for others to

carry out similar investigations or response activities,

You are welcome to invite other colleagues to this call as you think

relevant for example those engaged in the response planning / working

with schools etc.

Attached you will find a preliminary agenda. WebEx connection details

will be sent closer to the meeting.

CALL FOR PRESENTATIONS: If your country has done any work that is

relevant to the three points above that you would be happy to share

please email by April 17th. This will help us plan the agenda.

Please let us know if you have any questions! Very much looking forward

to engaging with you on this important topic.

Kind regards,

Lina Nerlander and Otilia Mardh

Ad hoc workshop to exchange information on increase of STIs in EU/EEA, in

particular among young heterosexualsMonday, 29 April 2024

12:00 | (UTC+02:00) Amsterdam, Berlin, Bern, Rome, Stockholm,

Vienna | 4 hrs 30 mins

JOIN BY COMPUTER/TABLET/SMART PHONE:

To join the meeting on computer/tablet/smart phone, please follow this

link:

1. Fill in your full name and if possible, organisation

2. If asked, fill in the meeting password: CDCE

You now entering the meeting.

Welcome!

JOIN BY PHONE (Audio only):

To join the meeting using phone, dial this number 0046-851-992511 (Sweden

Toll)

Or find your local toll number from this link:

Wait for 5 seconds or until instructed.

Then dial the meeting number: 2744 072 9941 ##

You now entering the meeting.

Welcome!

JOIN BY VIDEO CONFERENCE SYSTEM:

If you join by video conference system dial

Dial the password for the meeting: 3232#

…………………

ECDC AV department recommendations to participants;

* For your identification in the meeting please always give your full

name and if possible, organisation/Country.

* Please prioritise using computer or VC room when joining the meeting,

to allow possibilities for screen and video sharing if needed.

* Make sure that you have a good internet connection, a good microphone

(preferably a headset if using the computer).

* Please make the call from a quiet room, with light coming from the

front, so you are well visible.

* Join the meeting in good time to able time to setup.

…………………

Confidentiality NoticeIf you are not the intended recipient of this

message, you are hereby kindly requested, to, consecutively, refrain from

disclosing its content to any third party, delete it and inform its

sender of the erroneous transmittal.